Literature DB >> 28720862

TRACERx Renal: tracking renal cancer evolution through therapy.

.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28720862     DOI: 10.1038/nrurol.2017.112

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  6 in total

1.  Implications of cancer evolution for drug development.

Authors:  Samra Turajlic; Charles Swanton
Journal:  Nat Rev Drug Discov       Date:  2017-04-28       Impact factor: 84.694

2.  Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.

Authors:  James J Hsieh; David Chen; Patricia I Wang; Mahtab Marker; Almedina Redzematovic; Ying-Bei Chen; S Duygu Selcuklu; Nils Weinhold; Nancy Bouvier; Kety H Huberman; Umesh Bhanot; Michael S Chevinsky; Parul Patel; Patrizia Pinciroli; Helen H Won; Daoqi You; Agnes Viale; William Lee; A Ari Hakimi; Michael F Berger; Nicholas D Socci; Emily H Cheng; Jennifer Knox; Martin H Voss; Maurizio Voi; Robert J Motzer
Journal:  Eur Urol       Date:  2016-10-15       Impact factor: 20.096

Review 3.  Metastasis as an evolutionary process.

Authors:  Samra Turajlic; Charles Swanton
Journal:  Science       Date:  2016-04-08       Impact factor: 47.728

4.  SnapShot: Renal Cell Carcinoma.

Authors:  Samra Turajlic; James Larkin; Charles Swanton
Journal:  Cell       Date:  2015-12-03       Impact factor: 41.582

5.  Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.

Authors:  Marco Gerlinger; Stuart Horswell; James Larkin; Andrew J Rowan; Max P Salm; Ignacio Varela; Rosalie Fisher; Nicholas McGranahan; Nicholas Matthews; Claudio R Santos; Pierre Martinez; Benjamin Phillimore; Sharmin Begum; Adam Rabinowitz; Bradley Spencer-Dene; Sakshi Gulati; Paul A Bates; Gordon Stamp; Lisa Pickering; Martin Gore; David L Nicol; Steven Hazell; P Andrew Futreal; Aengus Stewart; Charles Swanton
Journal:  Nat Genet       Date:  2014-02-02       Impact factor: 38.330

6.  Comprehensive molecular characterization of clear cell renal cell carcinoma.

Authors: 
Journal:  Nature       Date:  2013-06-23       Impact factor: 49.962

  6 in total
  8 in total

Review 1.  Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies.

Authors:  Narendra Wajapeyee; Romi Gupta
Journal:  Cancer Res       Date:  2021-09-16       Impact factor: 12.701

2.  Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy.

Authors:  Pavan Bachireddy; Elham Azizi; Cassandra Burdziak; Vinhkhang N Nguyen; Christina S Ennis; Katie Maurer; Cameron Y Park; Zi-Ning Choo; Shuqiang Li; Satyen H Gohil; Neil G Ruthen; Zhongqi Ge; Derin B Keskin; Nicoletta Cieri; Kenneth J Livak; Haesook T Kim; Donna S Neuberg; Robert J Soiffer; Jerome Ritz; Edwin P Alyea; Dana Pe'er; Catherine J Wu
Journal:  Cell Rep       Date:  2021-11-09       Impact factor: 9.995

Review 3.  Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.

Authors:  José I López; Javier C Angulo
Journal:  Curr Urol Rep       Date:  2018-01-27       Impact factor: 3.092

4.  Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.

Authors:  Samra Turajlic; Hang Xu; Kevin Litchfield; Andrew Rowan; Stuart Horswell; Tim Chambers; Tim O'Brien; Jose I Lopez; Thomas B K Watkins; David Nicol; Mark Stares; Ben Challacombe; Steve Hazell; Ashish Chandra; Thomas J Mitchell; Lewis Au; Claudia Eichler-Jonsson; Faiz Jabbar; Aspasia Soultati; Simon Chowdhury; Sarah Rudman; Joanna Lynch; Archana Fernando; Gordon Stamp; Emma Nye; Aengus Stewart; Wei Xing; Jonathan C Smith; Mickael Escudero; Adam Huffman; Nik Matthews; Greg Elgar; Ben Phillimore; Marta Costa; Sharmin Begum; Sophia Ward; Max Salm; Stefan Boeing; Rosalie Fisher; Lavinia Spain; Carolina Navas; Eva Grönroos; Sebastijan Hobor; Sarkhara Sharma; Ismaeel Aurangzeb; Sharanpreet Lall; Alexander Polson; Mary Varia; Catherine Horsfield; Nicos Fotiadis; Lisa Pickering; Roland F Schwarz; Bruno Silva; Javier Herrero; Nick M Luscombe; Mariam Jamal-Hanjani; Rachel Rosenthal; Nicolai J Birkbak; Gareth A Wilson; Orsolya Pipek; Dezso Ribli; Marcin Krzystanek; Istvan Csabai; Zoltan Szallasi; Martin Gore; Nicholas McGranahan; Peter Van Loo; Peter Campbell; James Larkin; Charles Swanton
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

5.  Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.

Authors:  Thomas J Mitchell; Samra Turajlic; Andrew Rowan; David Nicol; James H R Farmery; Tim O'Brien; Inigo Martincorena; Patrick Tarpey; Nicos Angelopoulos; Lucy R Yates; Adam P Butler; Keiran Raine; Grant D Stewart; Ben Challacombe; Archana Fernando; Jose I Lopez; Steve Hazell; Ashish Chandra; Simon Chowdhury; Sarah Rudman; Aspasia Soultati; Gordon Stamp; Nicos Fotiadis; Lisa Pickering; Lewis Au; Lavinia Spain; Joanna Lynch; Mark Stares; Jon Teague; Francesco Maura; David C Wedge; Stuart Horswell; Tim Chambers; Kevin Litchfield; Hang Xu; Aengus Stewart; Reza Elaidi; Stéphane Oudard; Nicholas McGranahan; Istvan Csabai; Martin Gore; P Andrew Futreal; James Larkin; Andy G Lynch; Zoltan Szallasi; Charles Swanton; Peter J Campbell
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

Review 6.  Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection.

Authors:  Michael Flynn; Lisa Pickering; James Larkin; Samra Turajlic
Journal:  Ther Adv Med Oncol       Date:  2018-06-12       Impact factor: 8.168

7.  Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.

Authors:  Judith Abécassis; Anne-Sophie Hamy; Cécile Laurent; Benjamin Sadacca; Hélène Bonsang-Kitzis; Fabien Reyal; Jean-Philippe Vert
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

8.  Next Generation Sequencing in Renal Cell Carcinoma: Towards Precision Medicine.

Authors:  Roy Elias; Akanksha Sharma; Nirmish Singla; James Brugarolas
Journal:  Kidney Cancer J       Date:  2019
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.